The bridge between classical and ‘synthetic’/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective
View/ Open
Author
Orsolini, Laura
Chiappini, Stephania
Papanti, Duccio
De Berardis, Domenico
Corkery, John Martin
Schifano, Fabrizio
Attention
2299/22074
Abstract
The critical spread and dissemination of novel psychoactive substances (NPS), particularly among the most vulnerable youngsters, may pose a further concern about the psychotic trajectories related to the intake of new synthetic drugs. The psychopathological pattern of the “new psychoses” appears to be extremely different from the classical presentation. Therefore, clinicians need more data on these new synthetic psychoses and recommendations on how to manage them. The present mini-review aims at deepening both the clinical, psychopathological features of synthetic/chemical NPS-induced psychoses and their therapeutic strategies, according to the different NPS classes implicated, by underlining the main differences with the “classical” psychoses. A comprehensive review was conducted using the PubMed/Medline database by combining the search strategy of free-text terms and exploding a range of MESH headings relating to the topics of novel psychoactive substances and synthetic/chemical psychoses as follows: {(Novel Psychoactive Substances[Title/Abstract]) AND Psychosis[Title/Abstract])} and for each NPS categories as well, focusing on synthetic cannabinoids and cathinones, without time and/or language restrictions. Finally, an overview of the main clinical and psychopathological features between classical versus NPS-induced chemical/synthetic psychoses is provided for clinicians working with dual disorders and addiction psychiatry. Further insight is given here on therapeutic strategies and practical guidelines for managing patients affected with synthetic/chemical NPS-induced psychoses.
Publication date
2019-11-20Published in
Frontiers in PsychiatryPublished version
https://doi.org/10.3389/fpsyt.2019.00851Other links
http://hdl.handle.net/2299/22074Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
New/emerging psychoactive substances and associated psychopathological consequences
Schifano, Fabrizio; Napoletano, Flavia; Chiappini, Stephania; Guirguis, Amira; Corkery, John; Bonaccorso, Stefania; Ricciardi, Angelo; Scherbaum, Norbert; vento, alessandro (2019-07-22)BackgroundThe present paper provides an updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification ... -
Aberrant salience in cannabis-induced psychosis: a comparative study
Ricci, Valerio; Di Muzio, Ilenia; Ceci, Franca; Di Carlo, Francesco; Mancusi, Gianluca; Piro, Tommaso; Paggi, Andrea; Pettorruso, Mauro; Vellante, Federica; De Berardis, Domenico; Martinotti, Giovanni; Maina, Giuseppe (2024-01-08)Background: Natural Cannabis (NC) and Synthetic Cannabinoids (SCs) use can increase the risk and exacerbate the course of psychotic disorders. These could be influenced by the Aberrant Salience (AS) construct. It refers ... -
"..it depends on the risk." Constructing 'Antipsychotic' Medication 'Refusal' in Community 'Mental Health' Services
Westwood, Sally (2011-02-18)Aim Antipsychotic medication is the predominant intervention used for psychosis in the UK. However, there are risks associated, it is not always effective and service-users express ambivalence towards taking it. The ...